期刊文献+

逆转录病毒载体介导的端粒酶抑制基因促进肝癌细胞凋亡 被引量:2

Apoptosis of BEL-7402 cell line mediated by retroviral vector containing antisense human telomerase RNA
下载PDF
导出
摘要 目的:探讨逆转录病毒载体介导的反义端粒酶抑制基因对肝癌细胞系BEL-7402的凋亡诱导作用.方法:用电穿孔的方法把正、反义端粒酶抑制基因导入包装细胞,包装出完整的病毒,用此病毒感染肝癌细胞系BEL-7402,绘制细胞生长曲线来研究其抗肿瘤疗效.应用MTT、流式细胞术研究细胞凋亡情况.结果:肿瘤细胞感染逆转录病毒后,肿瘤生长受到明显抑制,转染反义hTR病毒组BEL-7402细胞凋亡率显著高于转染正义hTR病毒和生理盐水组(61.32%±2.24%vs23.02%±2.13%,4.11%±1.00%,P<0.01),转染反义hTR与5-FU联用细胞凋亡率更高,为71.71%±2.53%.结论:反义端粒酶抑制基因能明显抑制肿瘤细胞的体外生长,与抗肿瘤药物5-FU有协同作用,联合用药可以增强疗效,具有明显抗肿瘤作用. AIM: To investigate the apoptosis-inducing effect of retroviral vector containing antisense human telomerase RNA (hTR) on hepatocellular carcinoma (HCC) cell line BEL-7402. METHODS: The complete virus was obtained by importing the sense and antisense hTR into the PT67 cell line with electroporation. Bel-7402 cell line was then transfected with the virus. The therapeutic effect was evaluated by cell growth curve. MTr assay and flow cytometry were used to investigate the apoptosis of BEL-7402 cells. RESULTS: After transfection with retroviral vector, the growth of BEL-7402 cells was obviously inhibited. The apoptotic rate was significantly higher in the cells transfected with antisense hTR than that in the cells transfected with sense hTR and normal saline controls (61.32% ± 2.24% vs 23.02% ± 2.13%, 4.11% ± 1.00%, P 〈 0.01), and the apoptotic rate was more significant when the antisense hTR-transfected cells were treated with 5-FU (71.71% ± 2.53%). CONCLUSION: hTR can induce significant apoptosis of BEL-7402 cell line, and it plays a synergic role with 5-FU.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第10期989-992,共4页 World Chinese Journal of Digestology
基金 山东省医药卫生科研项目 No.CAIDBA3
关键词 重组逆转录病毒载体 基因疗法 肝细胞癌 反义HTR Recombinant retroviral vector Gene therapy Hepatocelluler cancer Antisense human telomerase RNA
  • 相关文献

参考文献9

二级参考文献7

共引文献20

同被引文献23

  • 1王丛笑,刘吉勇,赵跃然,焦玉莲,马春燕,杨崇美.正反义人端粒酶RNA组分(hTR)逆转录病毒真核表达载体的构建[J].中国肿瘤生物治疗杂志,2005,12(1):51-51. 被引量:5
  • 2Kim N W.Advances in quantification and characterizationof telomerase activity by the telomeric repeat amplificationprotocol(TRAP)[J].Nucleic Acids Res,1997,25(3):2595-2597.
  • 3Yamaguchi T,Takahashi H,Harada Y,et al.Telomereshortening in human HL60 cells by treatment w ith deox-yguanosine analogs[J].Nucleic Acids Symp Ser(Oxf.),2004,48:187-188.
  • 4Melana S M,Holland J F,Pogo B G.Inhibition of cellgrow th and telomerase activity of breast cancer cells invitro by 3'-azido-3'deoxythymidine[J].Clin CancerRes,1998,4(3):693-696.
  • 5Mo Y,Gan Y,Song S,et al.Simultaneous targeting oftelomeres and telomerase as a cancer therapeutic approach[J].Cancer Res,2003,63(3):579-583.
  • 6Liu H,Hung Y,Wissink S D,et al.Improved retroviraltransduction of hematopoietic progenitors by combiningmethods to enhance virus-cell interaction[J].Leukemia,2000,14(2):307-311.
  • 7Crystal R G.Transfer of genes to humans:early lessonsand obstacles to success[J].Science,1995,270:404-410.
  • 8Kirsch D G,Doseff A,Chau B N,et al.Caspase-3-de-pendent cleavage of Bcl-2 promotes release of cytochromec[J].J Biol Chem,1999,274(30):21155-21161.
  • 9Bedi A,Mookeriee B.Biological significance and mo-lecular mechanisms of p53-induced apoptosis[J].Ap-optosis,1998,3(4):237-244.
  • 10Gavrieli Y,Sherman B,Sasson S A,et al.Identifica-tion of programmed cell death in situ via specific labelingof nuclear DNA fragmentation[J].J Cell Biol,1992,119(3):493-501.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部